Skip to main content

Table 5 Clinicopathological characteristics according to BRAF V600E mutation status in 126 colon cancer patients

From: BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients

  BRAF codon 600 mutation
   No (%) Yes (%) P
Sex male 71 (60.2) 5 (62.5) 1.000b
  female 47 (39.8) 3 (37.5)  
Age   69.4 65.4 0.664d
Differentiation well 15 (12.7) 1 (12.5) 0.192c
  moderate 91 (77.1) 3 (37.5)  
  poor 5 (4.2) 2 (25.0)  
  missing 7 (5.9) 2 (25.0)  
Tumor diameter <5 cm 49 (41.5) 2 (25.0) 0.469b
  > = 5 cm 67 (56.8) 6 (75.0)  
  missing 2 (1.7) 0 (0)  
TNM-stage I 9 (7.6) 0 (0) 0.014 c
  II 50 (42.4) 2 (25.0)  
  III 49 (42.4) 2 (25.0)  
  IV 7 (5.9) 4 (50.0)  
  missing 2 (1.7) 0 (0)  
T T1 0 (0) 0 (0) 0.106c
  T2 9 (7.6) 0 (0)  
  T3 105 (89.0) 7 (87.5)  
  T4 2 (1.7) 1 (12.5)  
  missing 2 (1.7) 0 (0)  
N N(−) 62 (52.5) 2 (25.0) 0.157b
  N(+) 55 (46.6) 6 (75.0)  
  missing 1 (0.8) 0 (0)  
Metastases M(−) 91 (77.1) 3 (37.5) 0.025 b
  M(+) 27 (22.9) 5 (62.5)  
Synchronous metastases M(−) 110 (93.2) 4 (50.0) 0.002 b
  M(+) 7 (5.9) 4 (50.0)  
  missing 1 (0.8) 0 (0)  
Metachronous metastases M(−) 96 (81.4) 4 (50.0) 0.056b
  M(+) 22 (18.6) 4 (50.0)  
  1. bFisher exact test; cMann–Whitney test; dt test. P-values ≤ 0.05 are in bold.